Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010 | 4234* | 2010 |
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ... The Lancet 375 (9716), 735-742, 2010 | 3189 | 2010 |
Dietary supplementation with n3 polyunsaturated fatty acids and vitamin E after MI: results of the GP Trial Lancet 354, 447-55, 1999 | 2920* | 1999 |
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio … R Marchioli, F Barzi, E Bomba, C Chieffo, D Di Gregorio, R Di Mascio, ... Circulation 105 (16), 1897-1903, 2002 | 1985 | 2002 |
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis FS Collaboration Jama 294 (14), 1799-1809, 2005 | 1668 | 2005 |
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. L Tavazzi, AP Maggioni, R Marchioli, S Barlera, MG Franzosi, R Latini, ... Lancet (London, England) 372 (9645), 1223-1230, 2008 | 1665 | 2008 |
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. L Tavazzi, AP Maggioni, R Marchioli, S Barlera, MG Franzosi, R Latini, ... Lancet (London, England) 372 (9645), 1231-1239, 2008 | 1358 | 2008 |
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. L Tavazzi, AP Maggioni, R Marchioli, S Barlera, MG Franzosi, R Latini, ... Lancet (London, England) 372 (9645), 1231-1239, 2008 | 1357 | 2008 |
Efficacy and safety of low-dose aspirin in polycythemia vera R Landolfi, R Marchioli, J Kutti, H Gisslinger, G Tognoni, C Patrono, ... New England Journal of Medicine 350 (2), 114-124, 2004 | 1276 | 2004 |
Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... New England Journal of Medicine 368 (1), 22-33, 2013 | 949 | 2013 |
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera R Marchioli, G Finazzi, R Landolfi, J Kutti, H Gisslinger, C Patrono, ... Journal of Clinical Oncology 23 (10), 2224-2232, 2005 | 877 | 2005 |
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 733 | 2015 |
Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals T Aung, J Halsey, D Kromhout, HC Gerstein, R Marchioli, L Tavazzi, ... JAMA cardiology 3 (3), 225-233, 2018 | 724 | 2018 |
A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid … G Finazzi, R Marchioli, V Brancaccio, P Schinco, F Wisloff, J Musial, ... Journal of Thrombosis and Haemostasis 3 (5), 848-853, 2005 | 698 | 2005 |
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease Statistical genetics and bioinformatics Goel Anuj 1 2 Ongen Halit 1 2 ... Nature genetics 43 (4), 339-344, 2011 | 684 | 2011 |
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 669 | 2019 |
n–3 fatty acids in patients with multiple cardiovascular risk factors Risk and Prevention Study Collaborative Group New England Journal of Medicine 368 (19), 1800-1808, 2013 | 660 | 2013 |
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ... Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007 | 634 | 2007 |
Polycythemia vera: the natural history of 1213 patients followed for 20 years GIS Policitemia Annals of Internal Medicine 123 (9), 656-664, 1995 | 600 | 1995 |
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study G Finazzi, V Caruso, R Marchioli, G Capnist, T Chisesi, C Finelli, ... Blood 105 (7), 2664-2670, 2005 | 561 | 2005 |